| Todd Jerry Lehrfeld, MD | |
|
403 Bethel Rd, Somers Point, NJ 08244-2188 | |
| (609) 927-8746 | |
| (609) 601-1406 |
| Full Name | Todd Jerry Lehrfeld |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 23 Years |
| Location | 403 Bethel Rd, Somers Point, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235273848 | NPI | - | NPPES |
| 208800000X | Other | TAXONOMY CODE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD431651 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cape Regional Medical Center Inc | Cape may court house, NJ | Hospital |
| Shore Medical Center | Somers point, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cape Physicians Associates Pa | 0749333730 | 97 |
| Shore Specialty Consultants | 1951613652 | 37 |
| Jersey Urology Group P. A. | 2264434703 | 12 |
News Archive
Researchers at Winship Cancer Institute are developing a technique to remove cancer cells' defenses against radiation.
President Obama announced yesterday nearly $600 million in American Recovery and Reinvestment Act grant awards to fund major construction and renovation projects at a total of 85 community health centers nationwide, including a $6.5 million award to Esperanza Health Center in North Philadelphia.
A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.
OncoGenex Pharmaceuticals, Inc. announced today that the European Medicines Agency has completed its review of the proposed amendment to the company's Phase 3 AFFINITY protocol and statistical analysis plan.
› Verified 4 days ago
| Entity Name | Jersey Urology Group P. A. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225193162 PECOS PAC ID: 2264434703 Enrollment ID: O20070212000660 |
News Archive
Researchers at Winship Cancer Institute are developing a technique to remove cancer cells' defenses against radiation.
President Obama announced yesterday nearly $600 million in American Recovery and Reinvestment Act grant awards to fund major construction and renovation projects at a total of 85 community health centers nationwide, including a $6.5 million award to Esperanza Health Center in North Philadelphia.
A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.
OncoGenex Pharmaceuticals, Inc. announced today that the European Medicines Agency has completed its review of the proposed amendment to the company's Phase 3 AFFINITY protocol and statistical analysis plan.
› Verified 4 days ago
| Entity Name | Cape Physicians Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003805227 PECOS PAC ID: 0749333730 Enrollment ID: O20090928000078 |
News Archive
Researchers at Winship Cancer Institute are developing a technique to remove cancer cells' defenses against radiation.
President Obama announced yesterday nearly $600 million in American Recovery and Reinvestment Act grant awards to fund major construction and renovation projects at a total of 85 community health centers nationwide, including a $6.5 million award to Esperanza Health Center in North Philadelphia.
A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.
OncoGenex Pharmaceuticals, Inc. announced today that the European Medicines Agency has completed its review of the proposed amendment to the company's Phase 3 AFFINITY protocol and statistical analysis plan.
› Verified 4 days ago
| Entity Name | Shore Specialty Consultants |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962808519 PECOS PAC ID: 1951613652 Enrollment ID: O20150709001185 |
News Archive
Researchers at Winship Cancer Institute are developing a technique to remove cancer cells' defenses against radiation.
President Obama announced yesterday nearly $600 million in American Recovery and Reinvestment Act grant awards to fund major construction and renovation projects at a total of 85 community health centers nationwide, including a $6.5 million award to Esperanza Health Center in North Philadelphia.
A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.
OncoGenex Pharmaceuticals, Inc. announced today that the European Medicines Agency has completed its review of the proposed amendment to the company's Phase 3 AFFINITY protocol and statistical analysis plan.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Todd Jerry Lehrfeld, MD 403 Bethel Rd, Somers Point, NJ 08244-2188 Ph: (609) 927-8746 | Todd Jerry Lehrfeld, MD 403 Bethel Rd, Somers Point, NJ 08244-2188 Ph: (609) 927-8746 |
News Archive
Researchers at Winship Cancer Institute are developing a technique to remove cancer cells' defenses against radiation.
President Obama announced yesterday nearly $600 million in American Recovery and Reinvestment Act grant awards to fund major construction and renovation projects at a total of 85 community health centers nationwide, including a $6.5 million award to Esperanza Health Center in North Philadelphia.
A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.
OncoGenex Pharmaceuticals, Inc. announced today that the European Medicines Agency has completed its review of the proposed amendment to the company's Phase 3 AFFINITY protocol and statistical analysis plan.
› Verified 4 days ago
Meredith P Jankowski, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 403 Bethel Rd, Somers Point, NJ 08244 Phone: 609-927-8746 Fax: 609-601-1406 | |
Michael A Piskun, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 403 Bethel Rd, Somers Point, NJ 08244 Phone: 609-927-8746 Fax: 609-601-1406 | |
Michael J Schutz, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 403 Bethel Rd, Somers Point, NJ 08244 Phone: 609-927-8746 Fax: 609-601-1406 | |
Andre Ciceron, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 207 Shore Rd, Somers Point, NJ 08244 Phone: 609-926-5838 Fax: 609-926-5839 | |
Dr. Gene J Braga, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 229 Shore Rd, Somers Point, NJ 08244 Phone: 609-653-4343 Fax: 609-601-9630 | |
William M Wixted, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 731 Bay Ave, Somers Point, NJ 08244 Phone: 609-653-1863 Fax: 609-601-1406 |